UCB : Presents Latest Data from Generalized Myasthenia Gravis Portfolio at 9th Congress of the European Academy of Neurology (EAN) Meeting

UCB Presents Latest Data from Generalized Myasthenia Gravis Portfolio at 9th Congress of the European Academy of Neurology Meeting




Results presented across...

Related Keywords

Japan ,Denmark ,Belgium ,Brussels ,Bruxelles Capitale ,Japanese ,Antje Witte ,Donatello Crocetta ,Laurent Schots ,Manuela Maronati ,Jim Baxter ,Drug Administration ,Devices Agency ,Twitter ,Global Communications ,Corporate Communications ,European Medicines Agency ,Japanese Pharmaceuticals ,Myasthenia Gravis Foundation Of America ,European Academy Of Neurology ,European Commission ,European Academy ,Meeting July ,Priority Review ,Biologic License Application ,Medical Devices Agency ,Global Rare Disease ,Rare Medical ,Myasthenia Gravis Awareness Month ,Rare Disease ,Marketing Authorization Application ,Generalized Myasthenia Gravis ,Euronext Brussels ,Test Efficacy ,Adult Patients With Generalized Myasthenia ,Accessed June ,Subjects With Generalized Myasthenia Gravis ,Patients With Moderate ,Severe Generalized Myasthenia Gravis ,Multicenter Clinical ,Gravis Foundation ,Clinical Overview ,Medicines Agency ,